CLINICAL_TRIALS
research
· 2024-12-03
Clinical Trial Update: Trilaciclib Combing Chemotherapy in the Neoadjuvant Treatment of Osteosarcoma [Phase 2]
Summary
This is a status update on a Phase 2 trial evaluating trilaciclib with chemotherapy for osteosarcoma, currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Peking University People's Hospital | Conditions: Osteosarcoma | Phase 2 | Status: RECRUITING